Partnerstudie – EMERGE Cryo

The “EMERGE Cryo Study” From the Emergency department directly to ablation of atrial fibrillation

The study is a prospective, two-arm, randomized, open-label, blinded endpoint, multicenter study to investigate the impact of first line ablation in patients presenting at the emergency room with recent-onset paroxysmal or persistent atrial fibrillation.

The purpose of the study is to investigate the impact of early ablation in patients presenting at the emergency room with recent-onset paroxysmal or persistent atrial fibrillation.

n=350

Principal Investigator

Cardiology and internal intensive care medicine, Asklepios Klinik St. Georg

Committee Support